1
UP-3.042 Clinical Observation of Prophylactic Intravesical Instillation of Pirurubicin (THP) in the Effects of Postoperative Quality of Life in Patients with Superficial Bladder Cancer Zheng Z, Li M, Chen X, Yan M, Yang X Beijing Cancer Hospital, Beijing, China Introduction and Objective: To evaluate the effects and safety of prophylactic in- travesical instillation of pirurubicin (THP) to superficial bladder cancer after TUR-Bt or bladder partial resection. Materials and Methods: Eighty-seven patients were selected, and all these pa- tients had received TUR-Bt or bladder par- tial resection because of superficial blad- der tumor, and they were followed up for 3-60 months. After the operation, THP (30mg/30ml) was instilled into bladder, then stayed for 30-45 min. In the follwing eight weeks, intravescial instllation of piruruvicin was administered once a week. After the instllation for eight weeks, it was done once a month for eight months. And these patients ac- cepted cystoscopy per three months, if found recurrence, they should have an- other operation. Results: In our observation of 87 pa- tients, we found 19 patients had urinary irritation symptoms, 14 felt bladder un- well, 5 had dysuria, 4 was sleepless and remarkably 17 had psychological alter- ation for warrying about bladder instilla- tion, cystoscopy, recurrence and metasta- sis. Conclusion: Intravesical instillation of pirurubicin is an effective method to pre- vent recurrence, but the side effect was mainly local reaction, and will obviously relieve in short time after therapy. How- ever, we should pay attention to some patients with psychological alteration, we should take suitable method to instill piru- rubicin and have correct instruction to eliminate their worries. UP-3.043 High Glucose Concentration Increase Human Prostatic Stromal Cells (HPSC) Contraction Mediated by Protein Kinase C-Alpha (PKC-Alpha) Isozyme Activity Purnomo B, Wayan Widharse, Aulani’an Department of Urology, Medical School Brawijaya University, Saiful Anwar Hos- pital, Malang, Indonesia Introduction and Objective: Several studies have suggested a specific associa- tion between severity symptom of benign prostatic hyperplasia (BPH) and diabetes mellitus. Some studies have also proved that increasing protein kinase C (PKC) alpha isozyme activity after glucose expo- sure is a factor that increasing contraction in vascular smooth muscle cell culture. Increasing contraction of prostatic stromal cells was known as dynamic component of prostatic obstruction. This in vitro ex- periment proved that glucose treatment in human prostatic stromal cells (HPSC) cul- ture would increase PKC alpha isozyme activity. Materials and Methods: Primary cultures of HPSC were obtained from patients with bladder outlet obstruction caused by be- nign prostatic enlargement. The cells were incubated in various concentrations of glucose (5, 10, 15, 20, 25, 30, 35 mi- cro-Mol) for 48 hours. The activity of PKC-alpha isozyme from various glucose concentrations were examined quantita- tively by spectrophotometry methods. The effects of glucose on cells contractility were examined by counting the percent- age of cells that contract after administra- tion of 1, 10, and 100 micro-Mol of phen- ylephrine. Results: Exposures to various doses of glucose resulted in increased isozyme ac- tivity. The increment of activity is linear with the increment of glucose dose. There is a strong correlation between glu- cose doses and PKCalpha activity, with R20.91. The result showed that adminis- tration of 10 micro-M ol phenylephrine give the strongest contraction effect (54 6.37%) compared to 1 micro-Mol (34 3.37%) and 100 micro-M ol (25.75 2.22%). The percentage of contraction induced by various dose of phenylephrine would be increased, if the cells incubated in 20 micro-Mol glucose for 48 hours be- fore phenylephrine administration. The percentage of contraction would in- creased to 14.25 3.03% after exposure to 1 micro-Mol phenypephrine (p0,002); 20 3.03% after 10 micro-Mol pheyleph- rine (p0,000), and 7.5 3.03% after 100 micro-M ol phenylephrine (p0,183). Conclusions: At different concentrations, glucose increases HPSC contraction, medi- ated by PKCalpha isozyme. UP-3.044 Benign Prostatic Hyperplasia: Histologic Confirmation of an Ever- Progressing Disease Vela-Navarrete R 1 , Manzarbeitia F 2 , Sarasa J 2 , Fernadez Acen ˜ero M 2 , Gonzalez Enguita C 1 1 Urology, Fundacion Jimenez Diaz Uni- versity Hospital, Madrid; 2 Pathology, Fundacion Jimenez Diaz University Hos- pital, Madrid, Spain Introduction and Objective: BPH mor- phogenesis starts from initial mesenquimal nodules and myxoid primitive structures usually localized in the periurethral zone (transition zone). It has been supposed that the younger is an individual the more of these structures would be identified in the samples coming from TURP or open adenomectomy. We challenged this hy- pothesis when looking for the role of mononuclear cells infiltration on these primitive structures. Materials and Methods: Tissue samples removed from 70 patients who underwent TURP were studied. The average age of this population group was 70.8 (57-97), with an average tissue weight of 24.0 g (2-200 g). Areas of myxoid nodules or myxoid hyperplasia were identified during routine evaluation and selected for special staining (Vimentin, smActin and Desmin) or processed conventionally using immu- nohistochemistry CD 3 , CD 20 , CD 68 , CD 34 . The number of myxoid nodules or myx- oid hyperplasia was counted in each sam- ple. Results: Myxoid and fibromyxoid nodules were identified in variable proportion. Many of them were localized in the subu- rotelial corion or interlaced with the smooth muscle of the sphincter. The most common size was 0.2-5.0 mm. Next to them were fibromuscular nodules of big- ger size (5mm), positive for Vimentin, reduced expression of smActin and nega- tive expression of Desmin. A constant and uniform infiltration of B and T lympho- cytes was present with occasional histio- cytes and mast cells. Glandular perme- ation at this stage was uncommon. Surprisingly when compared the younger population group (57 years) with the older (80 years) it was discovered that these initial mesenchyme structures were more common in the older population group (0.330.7 vs. 2.002.7: p0.02). Conclusions: Progression of BPH in early stages means a process of maturation from myxoid and fibromyxoid nodules far before glandular permeation is observed. Contrary to the expected decline of this activity with age, histology confirms that BPH is an ever-progressing disease. UP-3.045 Tissue Effects of Greenlight HPS™ and Evolve SLV™ Lasers on Canine Prostates: An Acute In-Vivo Model Wong C 1 , Spaliviero M 1 , Wolf R 1 , Kosanke S 1 , Chavez-Suarez M 1 , Broach F 1 , Araki M 2 1 Department of Urology, University of Oklahoma Health Sciences Center, Okla- homa City, USA; 2 Okayama University, Okayama, Japan UNMODERATED POSTER SESSIONS UROLOGY 74 (Supplment 4A), October 2009 S307

UP-3.042: Clinical Observation of Prophylactic Intravesical Instillation of Pirurubicin (THP) in the Effects of Postoperative Quality of Life in Patients with Superficial Bladder Cancer

  • Upload
    z-zheng

  • View
    217

  • Download
    2

Embed Size (px)

Citation preview

Page 1: UP-3.042: Clinical Observation of Prophylactic Intravesical Instillation of Pirurubicin (THP) in the Effects of Postoperative Quality of Life in Patients with Superficial Bladder Cancer

UCI(QSZB

ItttoMpttd3(tepwwecfoRtiwratsCpvmrepsre

UHHCKAPDBp

Istpm

tasiIcophtaMobnwocPctewatyRgtwTcRtg632iwifpct2r1Cga

UBHPVSE1

vF

Ipnu(totapmpMrTtw(mrsonTopRwMrsctgrtuccaSpotmgCsfbCaB

UTEPWS1

Oh

UNMODERATED POSTER SESSIONS

U

P-3.042linical Observation of Prophylactic

ntravesical Instillation of PirurubicinTHP) in the Effects of Postoperativeuality of Life in Patients withuperficial Bladder Cancerheng Z, Li M, Chen X, Yan M, Yang Xeijing Cancer Hospital, Beijing, China

ntroduction and Objective: To evaluatehe effects and safety of prophylactic in-ravesical instillation of pirurubicin (THP)o superficial bladder cancer after TUR-Btr bladder partial resection.aterials and Methods: Eighty-seven

atients were selected, and all these pa-ients had received TUR-Bt or bladder par-ial resection because of superficial blad-er tumor, and they were followed up for-60 months. After the operation, THP30mg/30ml) was instilled into bladder,hen stayed for 30-45 min. In the follwingight weeks, intravescial instllation ofiruruvicin was administered once aeek. After the instllation for eighteeks, it was done once a month for

ight months. And these patients ac-epted cystoscopy per three months, ifound recurrence, they should have an-ther operation.esults: In our observation of 87 pa-

ients, we found 19 patients had urinaryrritation symptoms, 14 felt bladder un-

ell, 5 had dysuria, 4 was sleepless andemarkably 17 had psychological alter-tion for warrying about bladder instilla-ion, cystoscopy, recurrence and metasta-is.onclusion: Intravesical instillation ofirurubicin is an effective method to pre-ent recurrence, but the side effect wasainly local reaction, and will obviously

elieve in short time after therapy. How-ver, we should pay attention to someatients with psychological alteration, wehould take suitable method to instill piru-ubicin and have correct instruction toliminate their worries.

P-3.043igh Glucose Concentration Increaseuman Prostatic Stromal Cells (HPSC)ontraction Mediated by Proteininase C-Alpha (PKC-Alpha) Isozymectivityurnomo B, Wayan Widharse, Aulani’anepartment of Urology, Medical Schoolrawijaya University, Saiful Anwar Hos-ital, Malang, Indonesia

ntroduction and Objective: Severaltudies have suggested a specific associa-ion between severity symptom of benignrostatic hyperplasia (BPH) and diabetes

ellitus. Some studies have also proved p

ROLOGY 74 (Supplment 4A), October 2009

hat increasing protein kinase C (PKC)lpha isozyme activity after glucose expo-ure is a factor that increasing contractionn vascular smooth muscle cell culture.ncreasing contraction of prostatic stromalells was known as dynamic componentf prostatic obstruction. This in vitro ex-eriment proved that glucose treatment inuman prostatic stromal cells (HPSC) cul-ure would increase PKC alpha isozymectivity.aterials and Methods: Primary cultures

f HPSC were obtained from patients withladder outlet obstruction caused by be-ign prostatic enlargement. The cellsere incubated in various concentrationsf glucose (5, 10, 15, 20, 25, 30, 35 mi-ro-Mol) for 48 hours. The activity ofKC-alpha isozyme from various glucoseoncentrations were examined quantita-ively by spectrophotometry methods. Theffects of glucose on cells contractilityere examined by counting the percent-

ge of cells that contract after administra-ion of 1, 10, and 100 micro-Mol of phen-lephrine.esults: Exposures to various doses oflucose resulted in increased isozyme ac-ivity. The increment of activity is linearith the increment of glucose dose.here is a strong correlation between glu-ose doses and PKCalpha activity, with2�0.91. The result showed that adminis-

ration of 10 micro-M ol phenylephrineive the strongest contraction effect (54.37%) compared to 1 micro-Mol (34 �.37%) and 100 micro-M ol (25.75 �.22%). The percentage of contraction

nduced by various dose of phenylephrineould be increased, if the cells incubated

n 20 micro-Mol glucose for 48 hours be-ore phenylephrine administration. Theercentage of contraction would in-reased to 14.25 � 3.03% after exposureo 1 micro-Mol phenypephrine (p�0,002);0 � 3.03% after 10 micro-Mol pheyleph-ine (p�0,000), and 7.5 � 3.03% after00 micro-M ol phenylephrine (p�0,183).onclusions: At different concentrations,lucose increases HPSC contraction, medi-ted by PKCalpha isozyme.

P-3.044enign Prostatic Hyperplasia:istologic Confirmation of an Ever-rogressing Diseaseela-Navarrete R1, Manzarbeitia F2,arasa J2, Fernadez Acenero M2, Gonzaleznguita C1

Urology, Fundacion Jimenez Diaz Uni-ersity Hospital, Madrid; 2Pathology,undacion Jimenez Diaz University Hos-

ital, Madrid, Spain O

ntroduction and Objective: BPH mor-hogenesis starts from initial mesenquimalodules and myxoid primitive structuressually localized in the periurethral zonetransition zone). It has been supposedhat the younger is an individual the moref these structures would be identified inhe samples coming from TURP or opendenomectomy. We challenged this hy-othesis when looking for the role ofononuclear cells infiltration on theserimitive structures.aterials and Methods: Tissue samples

emoved from 70 patients who underwentURP were studied. The average age of

his population group was 70.8 � (57-97),ith an average tissue weight of 24.0 g

2-200 g). Areas of myxoid nodules oryxoid hyperplasia were identified during

outine evaluation and selected for specialtaining (Vimentin, smActin and Desmin)r processed conventionally using immu-ohistochemistry CD3, CD20, CD68, CD34.he number of myxoid nodules or myx-id hyperplasia was counted in each sam-le.esults: Myxoid and fibromyxoid nodulesere identified in variable proportion.any of them were localized in the subu-

otelial corion or interlaced with themooth muscle of the sphincter. The mostommon size was 0.2-5.0 mm. Next tohem were fibromuscular nodules of big-er size (�5mm), positive for Vimentin,educed expression of smActin and nega-ive expression of Desmin. A constant andniform infiltration of B and T lympho-ytes was present with occasional histio-ytes and mast cells. Glandular perme-tion at this stage was uncommon.urprisingly when compared the youngeropulation group (�57 years) with thelder (�80 years) it was discovered thathese initial mesenchyme structures wereore common in the older population

roup (0.33�0.7 vs. 2.00�2.7: p�0.02).onclusions: Progression of BPH in early

tages means a process of maturationrom myxoid and fibromyxoid nodules farefore glandular permeation is observed.ontrary to the expected decline of thisctivity with age, histology confirms thatPH is an ever-progressing disease.

P-3.045issue Effects of Greenlight HPS™ andvolve SLV™ Lasers on Caninerostates: An Acute In-Vivo Modelong C1, Spaliviero M1, Wolf R1, Kosanke

1, Chavez-Suarez M1, Broach F1, Araki M2

Department of Urology, University ofklahoma Health Sciences Center, Okla-oma City, USA; 2Okayama University,

kayama, Japan

S307